Source link : https://www.newshealth.biz/health-news/glp-1-reduces-recurrent-ischemic-stroke-in-type-2-diabetes/
Adding the glucagon-like peptide 1 receptor agonist (GLP-1 RA) liraglutide to standard therapy reduces the risk for recurrent stroke in patients with type 2 diabetes (T2D) and a minor acute ischemic stroke (AIS) or high-risk transient ischemic attack (TIA), results of a new study suggested. In addition, the study, which is the first large-scale trial […]
Author : News Health
Publish date : 2025-02-13 10:58:54
Copyright for syndicated content belongs to the linked Source.